Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peanut allergy.

A Wesley Burks1

  • 1Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC 27710, USA. wesley.burks@duke.edu

Lancet (London, England)
|May 6, 2008
PubMed
Summary
This summary is machine-generated.

Peanut allergy is a growing global health issue. This review covers its increasing prevalence, diagnosis, management, and emerging treatments for peanut allergy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old Children.

Allergy·2025
Same author

Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy.

The Journal of allergy and clinical immunology·2025
Same author

Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

To Eat or Not to Eat - Oral Immunotherapy for High-Threshold Peanut Allergy.

NEJM evidence·2025
Same author

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.

The journal of allergy and clinical immunology. In practice·2025
Same author

Epicutaneous immunotherapy for the treatment of peanut allergy.

Allergy·2024
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Immunology
  • Public Health
  • Allergology

Background:

  • Peanut allergy prevalence has significantly increased globally.
  • The exact causes for this rise in peanut allergy remain unclear.
  • Severe allergic reactions to peanuts pose significant health risks.

Purpose of the Study:

  • To examine the changing epidemiology of peanut allergy.
  • To explore theories behind the increasing prevalence of peanut allergy.
  • To review current and future strategies for peanut allergy diagnosis, management, and prevention.

Main Methods:

  • Literature review of epidemiological data on peanut allergy.
  • Analysis of proposed etiological factors for increased peanut allergy.
  • Synthesis of current diagnostic and management guidelines for peanut allergy.

Related Experiment Videos

  • Evaluation of emerging therapeutic and preventive approaches for peanut allergy.

    • Main Results:

    • The seminar discusses the increasing global burden of peanut allergy.
    • It explores various hypotheses, including hygiene hypothesis and dietary changes, for the rise in prevalence.
    • Current management emphasizes emergency preparedness, including epinephrine and antihistamines.
    • The need for patient education on recognition and avoidance of allergens is highlighted.

    Conclusions:

    • Prompt treatment with epinephrine is crucial for severe peanut allergy reactions.
    • Observation is recommended post-reaction due to potential late-phase responses.
    • Ongoing research focuses on novel treatments and prevention strategies for peanut allergy.
    • Comprehensive management involves education, avoidance, and emergency preparedness.